Immune responses to an upper body tri-set resistance training session.

Clin Physiol Funct Imaging

Exercise Physiology Laboratory - FISEX, School of Physical Education, University of Campinas (UNICAMP), Campinas, Brazil.

Published: January 2014

The purpose of this study was to evaluate the acute immune responses to an upper body tri-set resistance training (RT) session in RT trained individuals. Eighteen young trained men (22·0 ± 1·8 years) were randomly assigned to an exercise group (EG; n = 9) or control group (CG; n = 9). The EG completed an acute tri-set RT protocol using two combinations of three exercises for the same muscle group with six to eight repetitions at 75% of one repetition maximum (1RM) for each exercise. Blood samples were collected before (Pre), and 15 min (Post) and 24 h (P24h) after the acute RT protocol to determine basal and acute total leucocytes and leucocyte subsets counting, interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and cortisol. There were significant increases in total leucocytes, monocytes and neutrophils at Post as compared with Pre (P<0·05). Additionally, total leucocytes and monocytes were reduced even at P24h when compared to Pre (P<0·05). There were no significant changes in plasma concentrations of TNF-α, IL-6 and cortisol throughout the measured moments. As compared to CG, EG demonstrated very large effect sizes for total leucocytes, neutrophils and monocytes 15 min postprotocol and a reduction (trivial and small effect sizes) P24h. These results suggest that the tri-set RT session did not exacerbate the acute inflammatory response and might be a good option for variations in RT methods for trained individuals.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cpf.12066DOI Listing

Publication Analysis

Top Keywords

immune responses
8
responses upper
8
upper body
8
body tri-set
8
tri-set resistance
8
resistance training
8
training session
8
group n = 9
8
total leucocytes
8
session purpose
4

Similar Publications

Alzheimer's disease and antibody-mediated immune responses to infectious diseases agents: a mendelian randomization study.

Hereditas

January 2025

The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, No. 182 Chunhui Road, Longmatan District, Luzhou, Sichuan, 646000, China.

Background: Alzheimer's disease (AD) is a prevalent neurodegenerative disorder, with antibody-mediated immune responses to infectious diseases agents potentially playing a decisive role in its pathophysiological process. However, the causal relationship between antibodies and AD remains unclear.

Methods: A two-sample Mendelian randomization (MR) analysis was conducted to investigate the causal link between antibody-mediated immune responses to infectious diseases agents and the risk of AD.

View Article and Find Full Text PDF

Role of extracellular vesicles in the pathogenesis of mosquito-borne flaviviruses that impact public health.

J Biomed Sci

January 2025

Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), 04510, Mexico City, Mexico.

Mosquito-borne flaviviruses represent a public health challenge due to the high-rate endemic infections, severe clinical outcomes, and the potential risk of emerging global outbreaks. Flavivirus disease pathogenesis converges on cellular factors from vectors and hosts, and their interactions are still unclear. Exosomes and microparticles are extracellular vesicles released from cells that mediate the intercellular communication necessary for maintaining homeostasis; however, they have been shown to be involved in disease establishment and progression.

View Article and Find Full Text PDF

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.

Exp Hematol Oncol

January 2025

Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Zhejiang, China.

Background: Sequential CD19 and CD22 chimeric antigen receptor (CAR)-T cell therapy offers a promising approach to antigen-loss relapse in relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL); however, research in adults remains limited.

Methods: This study aimed to evaluate the efficacy and safety of sequential CD19 and CD22 CAR-T cell therapy in adult patients with R/R B-ALL between November 2020 and November 2023 (ChiCTR2100053871). Key endpoints included the adverse event incidence, overall survival (OS), and leukemia-free survival (LFS).

View Article and Find Full Text PDF

The role of genetic diversity, epigenetic regulation, and sex-based differences in HIV cure research: a comprehensive review.

Epigenetics Chromatin

January 2025

Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Penang, Malaysia.

Despite significant advances in HIV treatment, a definitive cure remains elusive. The first-in-human clinical trial of Excision BioTherapeutics' CRISPR-based HIV cure, EBT-101, demonstrated safety but failed to prevent viral rebound. These outcomes may result from the interplay of several factors.

View Article and Find Full Text PDF

Immunomodulatory insights of monoterpene glycosides in endometriosis: immune infiltration and target pathways analysis.

Hereditas

January 2025

Emergency Department, Ningbo Municipal Hospital of Traditional Chinese Medicine, Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, Zhejiang Province, China.

Endometriosis is a complex gynecological condition characterized by abnormal immune responses. This study aims to explore the immunomodulatory effects of monoterpene glycosides from Paeonia lactiflora on endometriosis. Using the ssGSEA algorithm, we assessed immune cell infiltration levels between normal and endometriosis groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!